Aki Tokuzumi
Kumamoto, 8608556, Japan
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 9 publications
Immunotherapy with 4-1BBL-Expressing iPS Cell-Derived Myeloid Lines Amplifies Antigen-Specific T Cell Infiltration in Advanced Melanoma.
Journal: International journal of molecular sciences
Published: January 06, 2021
Induced pluripotent stem cell-derived myeloid cells expressing OX40 ligand amplify antigen-specific T cells in advanced melanoma.
Journal: Pigment cell & melanoma research
Published: June 13, 2019
MicroRNAs that predict the effectiveness of anti-PD-1 therapies in patients with advanced melanoma.
Journal: Journal of dermatological science
Published: May 09, 2019
Serum concentrations of HGF are correlated with response to anti-PD-1 antibody therapy in patients with metastatic melanoma.
Journal: Journal of dermatological science
Published: January 31, 2018
AT-rich Interaction Domain-containing Protein 3B is a New Tumour Marker for Melanoma.
Journal: Acta dermato-venereologica
Published: May 04, 2016
Cell division cycle-associated protein 1 as a new melanoma-associated antigen.
Journal: The Journal of dermatology
Published: December 16, 2015
Serum long non-coding RNA, snoRNA host gene 5 level as a new tumor marker of malignant melanoma.
Journal: Experimental dermatology
Published: September 18, 2015
Investigation of FOXM1 as a Potential New Target for Melanoma.
Journal: PloS one
Published: May 22, 2015
Immunotherapy against Metastatic Melanoma with Human iPS Cell-Derived Myeloid Cell Lines Producing Type I Interferons.
Journal: Cancer immunology research
Published: April 10, 2015
Showing 1-9 of 9
Last Updated: 09/26/2026